GlaxoSmithKline is one of the five most valuable companies listed on the stock market. Breaking it up, in the way Mr Woodford is proposing, would mean the company changing radically and is likely to involve a heated conflict between …
BBC1y
Research Triangle Park, N.C. — Drug giants GlaxoSmithKline (NYSE ... Pfizer Chief Executive Officer Jeff Kindler in a joint statement issued to the London Stock Exchange. "With the strength of the companies' current HIV products, as …
GSK offered 3,900 rupees per share for stock in Indian-based GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS) during a tender period that ran from January 17 to January 30, with final payment due on or before February 13. The …
Aug 1, 2016 01:07 PM Form 6-K GLAXOSMITHKLINE PLC For: Aug 01 Aug 1, 2016 09:16 AM Form 6-K GLAXOSMITHKLINE PLC For: Aug 01 Jul 28, 2016 01:59 PM Form 6-K GLAXOSMITHKLINE PLC For: Jul 28 Jul 27, …
while GSK chose to get rid of the well-known brands to focus on its core pharmaceutical business. According to the Managing Director, Suntory Beverage and Food Nigeria, Mr. Chinedum Okereke, takeover procedures with the Nigerian …
Punch11mon
Drug developer Biota Holdings Ltd has been advised that the Japanese arm of global pharmaceutical firm GlaxoSmithKline (GSK) will increase its stock of the anti-flu drug Relenza, which Biota has licensed to GSK. GSK in …
Nomura maintains a reduce rating on GSK Pharma and has also slashed its 12-month target ... However, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back …
Over the long term, shares have proven very stable. Sometimes misconstrued as an American stock because the name is so popular, GlaxoSmithKline PLC (NYSE: GSK) is actually headquartered in the United Kingdom. Dividends are …
H1N1 swine flu vaccine maker GlaxoSmithKline released its fourth quarter profits ... with the majority of those sales coming in the first quarter of the year. The company’s stock has declined 2.5 per cent over the last 12 months.